Abstract
Objectives: This study assessed the influence of oral and topical sodium bicarbonate
(SB) on recovery and soccer-specific performance after exercise-induced muscle damage
(EIMD). Methods: In a randomized, double-blind, placebo-controlled, parallel group
design, 24 soccer players were allocated to oral SB, topical SB (PR Lotion, Momentous), or
placebo (PLA) (n = 8 per condition) and attended six laboratory sessions: (i) familiarization,
(ii) baseline measures, and (iii) four experimental trials on consecutive days. Muscle
damage was induced on day 1 using 40 × 15 m sprints, after which either 0.3 g·kg−1 body
mass (BM) SB (SB-ORAL), 0.9036 g·kg−1 BM PR Lotion (SB-LOTION), or an equivalent PLA
was given. Recovery outcomes were measured post-EIMD, 1 d, 2 d, and 3 d post (day 1–4).
Soccer-specific performance was repeated 3 d post, with supplements administered again
2 h pre-exercise. Recovery measures included muscle soreness, vertical jump height, and
maximal voluntary isometric contraction. Illinois agility test (IAT), 8 × 25 m repeated
sprints, and Yo-Yo Intermittent Recovery Test Level 2 (Yo-Yo IR2) were assessed as soccer-specific performance. Results: Neither SB-ORAL nor SB-LOTION accelerated indices of
recovery but decline in soccer-specific performance from baseline to 3 d post was attenuated
for SB-ORAL, with significant effects for IAT (p = 0.032, g = 1.69) and Yo-Yo IR2 (p = 0.026,
g = 1.61) compared with PLA. Conclusions: SB did not accelerate recovery following
EIMD but prescribing oral SB before subsequent exercise might rescue key performance
indicators. These findings offer implications for practitioners working with soccer players
during periods where full recovery is not achieved
(SB) on recovery and soccer-specific performance after exercise-induced muscle damage
(EIMD). Methods: In a randomized, double-blind, placebo-controlled, parallel group
design, 24 soccer players were allocated to oral SB, topical SB (PR Lotion, Momentous), or
placebo (PLA) (n = 8 per condition) and attended six laboratory sessions: (i) familiarization,
(ii) baseline measures, and (iii) four experimental trials on consecutive days. Muscle
damage was induced on day 1 using 40 × 15 m sprints, after which either 0.3 g·kg−1 body
mass (BM) SB (SB-ORAL), 0.9036 g·kg−1 BM PR Lotion (SB-LOTION), or an equivalent PLA
was given. Recovery outcomes were measured post-EIMD, 1 d, 2 d, and 3 d post (day 1–4).
Soccer-specific performance was repeated 3 d post, with supplements administered again
2 h pre-exercise. Recovery measures included muscle soreness, vertical jump height, and
maximal voluntary isometric contraction. Illinois agility test (IAT), 8 × 25 m repeated
sprints, and Yo-Yo Intermittent Recovery Test Level 2 (Yo-Yo IR2) were assessed as soccer-specific performance. Results: Neither SB-ORAL nor SB-LOTION accelerated indices of
recovery but decline in soccer-specific performance from baseline to 3 d post was attenuated
for SB-ORAL, with significant effects for IAT (p = 0.032, g = 1.69) and Yo-Yo IR2 (p = 0.026,
g = 1.61) compared with PLA. Conclusions: SB did not accelerate recovery following
EIMD but prescribing oral SB before subsequent exercise might rescue key performance
indicators. These findings offer implications for practitioners working with soccer players
during periods where full recovery is not achieved
| Original language | English |
|---|---|
| Article number | 3383 |
| Journal | Nutrients |
| Volume | 17 |
| Issue number | 21 |
| DOIs | |
| Publication status | Published (VoR) - 28 Oct 2025 |